Neuphoria Therapeutics Inc. - Common Stock
Neuphoria Therapeutics Inc. - Common Stock
Share · US64136E1029 · NEUP (XNAS)
Overview Financial Indicators
7,14 USD
-0,14 % -0,01 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
12.06.2025 19:59

Current Prices from Neuphoria Therapeutics Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
NEUP
USD
12.06.2025 19:59
7,14 USD
7,15 USD
-0,14 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 3,93 % 41,39 % 44,24 % 134,87 % 134,87 % 134,87 %

Company Profile for Neuphoria Therapeutics Inc. - Common Stock Share

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Company Data

Name Neuphoria Therapeutics Inc. - Common Stock
Company Neuphoria Therapeutics Inc.
Symbol NEUP
Website http://www.neuphoriatx.com
Primary Exchange XNAS NASDAQ
ISIN US64136E1029
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Dr. Spyridon Papapetropoulos M.D., Ph.D.
Country United States of America
Currency USD
Employees 0,0 T
Address , Burlington
IPO Date 2021-12-16

ID Changes

Date From To
24.12.2024 BNOX NEUP

Ticker Symbols

Name Symbol
NASDAQ NEUP

More Shares

Investors who Neuphoria Therapeutics Inc. - Common Stock hold also have the following shares in their portfolio:
BMW US CAP 19/22 FLR REGS
BMW US CAP 19/22 FLR REGS Bond
ZUGER KT.BK 12-37
ZUGER KT.BK 12-37 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025